Overview

Maximal Use Study to Determine the Pharmacokinetics of L-arginine After Exaggerated Oral Use of COL101

Status:
Completed
Trial end date:
2023-12-22
Target enrollment:
Participant gender:
Summary
Pharmacokinetic (PK) study of L-arginine after exaggerated oral use of the novel dentifrice product COL101 after repeated daily applications in healthy adult subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Colgate Palmolive
Treatments:
Fluorides
Listerine
Sodium Fluoride